Bioprocess Bags Market
Bioprocess Bags Market Trend, Opportunity, and Forecast Analysis, 2024-2032
Bioprocess Bags Market is segmented by Type, Workflow, End-user, and by Region. KDMI analyst foresees market revenue to cross USD 14.2 Billion by 2032 by growing with a CAGR of 18.1% during 2024-2032.
Bioprocess Bags Market Highlights
The global bioprocess bags market is expected to cross a value of USD 14.2 billion by the end of 2032. The market was valued at USD 3.97 billion in 2023 and is expected to expand at a CAGR of 18.1% between 2024-2032.
- Over the mid-term, the rise in demand for biopharmaceuticals is the primary factor anticipated to drive the global bioprocess bags market.
- The high cost of implementing bioprocess bag systems is a major factor to challenge the market growth.
- The North America bioprocess bags market is projected to dominate the global market.
Bioprocess Bags Market: Report Scope |
|
|
Base Year |
2023 |
|
Base Year Market Size |
USD 3.97 Billion |
|
Forecast Year |
2024-2032 |
|
Forecast Year Market Size |
USD 14.2 Billion |
|
CAGR Value |
18.1% |
|
Bioprocess Bags Market Key Trends/Major Growth Drivers |
|
|
Restraint Factors |
|
|
Bioprocess Bags Market Segmentation |
|
|
Bioprocess Bags Market Key Players |
Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation, Merck KGaA, Saint-Gobain, Corning Incorporated Entegris, Meissner Filtration Products, Inc., PROAnalytics, LLC, CellBios Healthcare And Lifesciences Pvt Ltd., and others. |
Bioprocess Bags Market Outlook
A flexible container that is designed for use in the biopharmaceutical and bioprocessing applications is known as bioprocess bag. These bags are typically made from specialized plastic films or polymers that are compatible with the requirements of bioprocesses, such as cell culture, fermentation, and purification.
One of the primary factors associated with the growth of the global bioprocess bags market, according to the analysts at KD Market Insights, is the rise in demand for biopharmaceuticals, such as monoclonal antibodies, and vaccines, along with the rapid advancements in bioprocess technology, which majorly include single-use systems and disposable bioprocess bags. Our experts predict that the revenue generated from single use bioprocessing by the end of 2032 would reach near to USD 31.2 billion. The biopharmaceutical industry is increasingly adopting single-use technologies, including bioprocess bags, for manufacturing biologics and other biopharmaceutical products. Single-use bioprocess bags offer advantages such as reduced contamination risk, lower cleaning and validation costs, and increased flexibility in bioprocessing operations. As biopharmaceutical manufacturers seek to improve operational efficiency and reduce capital expenditures, the demand for bioprocess bags is expected to grow. Thermo Fisher Scientific Inc., Sartorius AG, and Danaher Corporation are some of the significant parties in the global market for bioprocess bags.
Get More Insights on This Report - Request Free Sample PDF
Bioprocess Bags Market Drivers – Analyst’s Observation
According to the analysts at KD Market Insights, some key growth drivers for the global bioprocess bags market are:
- Surge in Demand for Personalized Medicines and Biologics: Over the recent years, the demand for biologics and personalized medicines has skyrocketed, supported majorly by the expanding biopharmaceutical industry. Our researchers predict that the personalized medicine industry would oversee a revenue of near to USD 1200 billion by 2032 by growing at a CAGR of near to 8.3% during the forecast period. Bioprocess bags play a critical role in biopharmaceutical manufacturing processes, including cell culture, fermentation, and purification. The expansion of biopharmaceutical manufacturing capacity, particularly in emerging markets, is therefore expected to drive the demand for bioprocess bags, aimed majorly at supporting the production scale-up and for meeting the growing market demand for biopharmaceutical products.
- Expanding Commercialization of Cell and Gene Therapies: Advanced therapies, such as cell and gene therapies, have specific unique requirements. As a result, the rise in development and commercialization of these advanced therapies is expected to raise the demand for bioprocess bags that are tailored to their unique requirements. It has been observed that for the manufacturing of cell-based and gene-based therapies, bioprocess bags play a crucial role, as these bags provide a sterile and closed-system environment for cell culture, gene delivery, and viral vector production. Hence, as the pipeline of cell and gene therapies continues to grow, the demand for specialized bioprocess bags is expected to increase.
Which Probable Factors Could Hamper the Growing Bioprocess Bags Market Trend?
As per our KD Market Insights analysis, some of the challenges expected to limit the global market growth of bioprocess bags are:
- High Cost of Implementing Bioprocess Bag Systems: The initial cost of implementing bioprocess bag systems is usually very high as compared to the traditional stainless steel systems, which is expected to limit the market growth.
- Challenges with Limited Compatibility: Bioprocess bags may not be compatible with all types of biopharmaceutical processes or materials. Certain bioprocesses may require specific materials or conditions that are not suitable for use with bioprocess bags, limiting their applicability in certain applications. This is therefore expected to hinder the expansion of the market in the coming years.
How is the Global Bioprocess Bags Market Segmented?
Our experts at KD Market Insights have segmented the global bioprocess bags market as:
|
By Type |
|
|
By Workflow |
|
|
By End-User |
|
|
By Region |
|
What are the Probable Factors Influencing the North America Bioprocess Bags Market Forecast?
The North America bioprocess bags market is majorly driven by the presence of a strong biopharmaceutical industry in the region, supported by expanding healthcare expenditure and robust healthcare infrastructural support from both the private and public players. Additionally, the increasing recognition of the regulatory bodies, such as the U.S. Food and Drug Administration (FDA) regarding the benefits associated with the use of single-use technologies in the manufacturing processes in the biopharmaceutical industry is also expected to contribute to the market growth in North America. Further, the market in the region is also witnessing an increase in the number of collaborations between bioprocess bag manufacturers, biopharmaceutical companies, and contract manufacturing organizations (CMOs), which is also expected to poise as a significant opportunity for market growth in the years to come.
As per our analysts at KD Market Insights, the following five players lead the North America bioprocess bags market growth:
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Entegris, Inc.
- Parker Hannifin Corporation
- Merck KGaA
|
Key Countries to Watch for in North America Bioprocess Bags Market |
Key Insights |
|
United States Bioprocess Bags Market to Register the Largest Regional Market Share |
USD 3.9 Billion |
|
Canada Bioprocess Bags Market to Grow with the Highest CAGR During 2024-2032 |
18.2% |
Which Key Players Top the Global Bioprocess Bags Market Share?
As per our analysts at KD Market Insights, the competitive landscape of global bioprocess bags market facilitates our readers in identifying their closest competitors. The manufacturers who are associated with bioprocess bags market are raising their focus on expanding their presence, as well as their market share. The market has also been witnessing an upward movement in the number of collaborations between research institutions and key players, aimed at introducing advanced technologies and innovation of new products. Here is a list of the key players who top the global bioprocess bags market share:
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Danaher Corporation
- Merck KGaA
- Saint-Gobain
- Corning Incorporated
- Entegris
- Meissner Filtration Products, Inc.
- PROAnalytics, LLC
- CellBios Healthcare and Lifesciences Pvt Ltd.
What are the Recent Developments Observed in the Bioprocess Bags Market?
Over the years, the experts at KD Market Insights have been observing the recent developments associated with global bioprocess bags market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.
For instance, Thermo Fisher Scientific, Inc. stated that it has opened a new manufacturing facility in Ogden, Utah. This new manufacturing facility would manufacture materials and technology required for developing vaccines and therapies.
Further, Saint Gobain shared that its Life Sciences division has partnered with Samsung Biologics for constructing an industrial installation of single-use systems for bioprocesses in Seoul.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
- Publication date: 23rd March 2024
- Base year: 2022
- Forecast year: 2023-2033
- Format: PDF, PPT,Word,Excel
- Quick Contact -
- ISO Certified Logo -
Frequently Asked Questions(FAQ)
Bioprocess Bags Market
-: Our Clients :-
